Free radical scavenging effect of donepezil as the possible contribution to its memory enhancing activity in mice

Drug Research

Volumn 64, Issue 5, 2014, Pages 236-239

  Umukoro, S ^a   Adewole, F A ^a   Eduviere, A T ^a   Aderibigbe, A O ^a   Onwuchekwa, C ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b USMANU DANFODIYO UNIVERSITY   (Nigeria)

Author keywords

antioxidant; donepezil; lipopolysaccharide; memory function

Indexed keywords

BIOLOGICAL MARKER; DONEPEZIL; FREE RADICAL; GLUTATHIONE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; SCOPOLAMINE; ANTIOXIDANT; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE; SCAVENGER; SCOPOLAMINE BROMIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN LEVEL; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; MALE; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; Y-MAZE TEST; ANIMAL; DRUG EFFECTS; MEMORY; MEMORY DISORDERS; METABOLISM;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; FREE RADICAL SCAVENGERS; FREE RADICALS; GLUTATHIONE; INDANS; LIPOPOLYSACCHARIDES; MALE; MALONDIALDEHYDE; MEMORY; MEMORY DISORDERS; MICE; OXIDATIVE STRESS; PIPERIDINES; SCOPOLAMINE HYDROBROMIDE;

EID: 84899945335     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0033-1357126     Document Type: Article

References (25)

1. Hsieh M. T., Peng W. H., Wu C. R. et al. Review on Experimental Research of Herbal Medicines with Anti-Amnesic Activity. Planta Med: 2010; 76 203 217
2. Salloway S., Correia S. Alzheimer disease: time to improve its diagnosis and treatment. Cleveland Clinic Journal of Medicine: 2009; 76 49 58
3. Tabet N., Mantle D., Orrell M. Free radicals as mediators of toxicity in Alzheimer's disease: a review and hypothesis. Adverse Drug Reaction and Toxicology Review: 2000; 19 127 152 (Pubitemid 30614519)
4. Blokland A. Scopolamine-induced deficits in cognitive performance: A review of animal studies. Scopolamine Review: 2005; 1 76
5. Markesbery W. R. Oxidative stress hypothesis in Alzheimer's disease. Free radical and Medical Biology: 1997; 23 134 147 (Pubitemid 27217017)
6. Holttum J. R., Gershon S. The cholinergic model of dementia, Alzheimer type: progression from the unitary transmitter concept. Dementia: 1992; 3 174 185
7. Moreira PI., Santos M. S., Oliveira C. R. et al. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurological Disorders and Drug Target: 2008; 7 3 10 (Pubitemid 351516211)
8. Amor S. F. Puentes Baker D., van der Valk P. Inflammation in neurodegenerative diseases. Immunology: 2010; 129 154 169
9. Fan Y., Hu J., Li J. et al. Effect of acidic oligosaccharide sugar chain on Scopolamine induced memory impairment in rats and its related mechanisms. Neuroscience Letters: 2005; 374 222 226 (Pubitemid 40128300)
10. Potter P. E. Curcumin: a natural substance with potential efficacy in Alzheimer's disease. Journal of experimental Pharmacology: 2013; 5 21 31
11. Jeong E. J., Lee Y. K., Kim S. H. et al. Cognitive enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice. European Journal of Pharmacology: 2008; 588 78 84
12. Myhrer T. Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Research Review: 2003; 41 268 287 (Pubitemid 36355883)
13. Casadesus G., Webber K. M., Atwood C. S. et al. Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochimica Biophysica Acta: 2006; 1762 447 452 (Pubitemid 43344306)
14. Patel V. P., Chu C. T. Nuclear transport, oxidative stress, and neurodegeneration. Int J Clin Exp Pathol: 2011; 4 215 229
15. Moron M. S., Depierre J. W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica ACTA: 1979; 582 67 78 (Pubitemid 9065588)
16. Okhawa H., Ohishi N., Yagi K. Assay for Lipid Peroxides in Animal Tissues by Thiobarbituric Acid Reaction Analytical Biochemistry: 1979; 952 351 358 (Pubitemid 9194347)
17. Dawson G. R., Heyes C. M., Iversen M. Pharmacological mechanisms and animal models of cognition. Behavioural Pharmacology: 1992; 3 286 297
18. Nakamura K., Kurasawa M., Tanaka Y. Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam. Drug Dev Res: 1998; 43 85 97 (Pubitemid 28281217)
19. Hooper N., Fraser C., Stone T. Effects of purine analogues on spontaneous alternation in mice. Psychopharmacology: 1996; 123 250 257 (Pubitemid 26074233)
20. Heo H. J., Kim M., Lee J. et al. Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dementia and Geratric Cognitive Disorders: 2004; 17 151 157 (Pubitemid 38339740)
21. Dunning J., During M. J. Molecular mechanisms of learning and memory. Expert Reviews in Molecular Medicine: 2003; 5 1 11
22. Lee S. T., Chu K., Sim J. Y. et al. Panx ginseng enhances cognitive performance in Alzheimer's Disease. Alzheimer's Disease and Associated Disorders: 2008; 22 222 226
23. Brito GN O., Davis B. J., Stopp L. C. et al. Memory and the septohippocampal cholinergic system in the rat. Psychopharmacology: 1983; 81 315 320 (Pubitemid 14209485)
24. Glass C. K., Kaoru S., Beate W. et al. Mechanisms underlying inflammation in neurodegeneration. Cell: 2010; 140 918 934
25. 2-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell: 2011; 145 584 595